Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 9INDUSTRY 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Ovarian Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Fallopian Tube Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Radiotherapy 9Radiosurgery 6Oxaliplatin 5Cisplatin 5Paclitaxel 4Capecitabine 4Leucovorin 3Irinotecan 3Fluorouracil 3Doxorubicin 3Docetaxel 3strontium chloride 2regorafenib 2pembrolizumab 2enzalutamide 2Zoledronic Acid 2Temozolomide 2Radiofrequency Ablation 2Mitomycin 2Methods 2Ifosfamide 2Gemcitabine 2Filgrastim 2Educational Status 2Early Intervention, Educational 2Bleomycin 2Bevacizumab 2Analgesia 2Albumin-Bound Paclitaxel 2trifluridine tipiracil drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplasm Metastasis × Dasatinib × Clear all
NCT00410813 2017-07-02

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

SWOG Cancer Research Network

Phase 2 Completed
85 enrolled 18 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡